Ultra-Sensitive DNA-Based NPM1 Mutation Detection Using superRCA on Flow Cytometry
Genes · 09.11.2026 · 17 (11) · 1419
DOI: 10.3390/genes17111419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 09.11.2026. Verfasst von Ann-Sofi Johansson und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
NPM1 mutations are established biomarkers for measurable residual disease (MRD) monitoring in acute myeloid leukemia (AML). RT-qPCR is widely used for NPM1 MRD assessment, but sensitive DNA-based methods offer advantages in sample stability and workflow. superRCA is a novel mutation detection technology that combines genotyping with rolling circle amplification to convert target molecules into fluorescent particles that can be enumerated by flow cytometry. Here, we evaluated the performance of superRCA for detection of the most common NPM1 variants, MutA, MutB, and MutD.
Methods
Analytical performance was assessed by determining limit of blank (LoB), limit of detection (LoD), limit of quantification (LoQ), precision, linearity, and cross-reactivity. Method comparison was performed using 83 biobanked clinical samples from patients with NPM1 MutA-positive AML previously analyzed by RT-qPCR, qPCR, ddPCR, and deep sequencing. Correlation, agreement, and positive and negative percent agreement (PPA/NPA) versus RT-qPCR were evaluated.
Results
The superRCA assay demonstrated LoD below 0.005% variant allele frequency (VAF) for all three NPM1 variants. Linearity was tested and demonstrated over 0.01–10.24% VAF. superRCA showed strong correlation with the other methods. Using LoD as the positivity threshold, PPA and NPA versus RT-qPCR detectable signal were 64% and 100%, respectively; using LoB, PPA was 89% and NPA 92%. Several superRCA-positive samples were negative by lower-input DNA methods. Conclusions: superRCA introduces ultra-sensitive molecular testing by combining sequence-specific DNA genotyping and flow cytometric enumeration. The NPM1 superRCA assay demonstrated low background, high sensitivity, precision, and broad linearity, with strong correlation with established molecular methods. These findings support further evaluation of superRCA for NPM1 MRD monitoring in AML.
Zitieren
APA
Johansson, A., Li, S., Alm, S. J., Ehinger, M., Fogelstrand, L., Chen, L., Bosaeus, L., & Engvall, M. (2026). Ultra-Sensitive DNA-Based NPM1 Mutation Detection Using superRCA on Flow Cytometry. Genes, 17(11), 1419. https://doi.org/10.3390/genes17111419
Vancouver
Johansson A, Li S, Alm SJ, Ehinger M, Fogelstrand L, Chen L, et al. Ultra-Sensitive DNA-Based NPM1 Mutation Detection Using superRCA on Flow Cytometry. Genes. 2026;17(11):1419. doi:10.3390/genes17111419
BibTeX
@article{Johansson2026,
author = {Johansson, Ann-Sofi and Li, Su-Chen and Alm, Sofie Johansson and Ehinger, Mats and Fogelstrand, Linda and Chen, Lei and Bosaeus, Linus and Engvall, Marie},
title = {Ultra-Sensitive DNA-Based NPM1 Mutation Detection Using superRCA on Flow Cytometry},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1419},
doi = {10.3390/genes17111419}
}
EUVIMED